STOCK TITAN

Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
conferences earnings clinical trial

Outset Medical (Nasdaq: OM) will release its third quarter 2025 financial results after market close on Monday, November 10, 2025. A conference call to discuss financial and operating results will be held the same day at 1:30 p.m. Pacific / 4:30 p.m. Eastern with Chair & CEO Leslie Trigg and CFO Renee Gaeta.

Interested participants must register online to receive dial-in numbers and a unique PIN; registrants are encouraged to join more than 15 minutes early. A live and archived webcast will be available on the company Investors website at https://investors.outsetmedical.com/.

Outset Medical (Nasdaq: OM) pubblicherà i suoi risultati finanziari del terzo trimestre 2025 dopo la chiusura del mercato lunedì 10 novembre 2025. Una conference call per discutere i risultati finanziari e operativi si terrà lo stesso giorno alle 13:30 ora del Pacifico / 16:30 ora orientale con la presidente e CEO Leslie Trigg e la CFO Renee Gaeta.

I partecipanti interessati devono registrarsi online per ricevere i numeri di accesso e un PIN unico; è consigliato ai registranti di collegarsi con oltre 15 minuti di anticipo. Una webcast dal vivo e archiviata sarà disponibile sul sito degli investitori dell'azienda all'indirizzo https://investors.outsetmedical.com/.

Outset Medical (Nasdaq: OM) publicará sus resultados financieros del tercer trimestre de 2025 después del cierre del mercado el lunes 10 de noviembre de 2025. Una llamada de conferencia para discutir los resultados financieros y operativos se llevará a cabo el mismo día a las 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este con la Presidenta y CEO Leslie Trigg y la CFO Renee Gaeta.

Los participantes interesados deben registrarse en línea para recibir números de marcación y un PIN único; se recomienda a los registrados unirse con más de 15 minutos de anticipación. Una transmisión en vivo y grabada estará disponible en el sitio web de inversores de la empresa en https://investors.outsetmedical.com/.

Outset Medical (나스닥: OM)2025년 3분기 실적을 시장 마감 후 2025년 11월 10일 월요일에 발표합니다. 재무 및 운영 실적을 논의하는 컨퍼런스콜은 같은 날 태평양 표준시 1:30 p.m. / 동부 표준시 4:30 p.m.에 의장 겸 CEO인 Leslie Trigg와 CFO Renee Gaeta와 함께 개최됩니다.

참가 희망자는 온라인으로 등록하여 다이얼인 번호와 고유 PIN을 받아야 하며, 등록자는 15분 이상 일찍 참여할 것을 권장합니다. 회사 투자자 웹사이트 https://investors.outsetmedical.com/에서 생방송 및 아카이브 웹캐스트를 이용할 수 있습니다.

Outset Medical (Nasdaq : OM) publiera ses résultats financiers du troisième trimestre 2025 après la clôture du marché le lundi 10 novembre 2025. Une conférence téléphonique pour discuter des résultats financiers et opérationnels aura lieu le même jour à 13h30, heure du Pacifique / 16h30, heure de l'Est avec la présidente et CEO Leslie Trigg et la CFO Renee Gaeta.

Les participants intéressés doivent s’inscrire en ligne pour recevoir des numéros d’appel et un code PIN unique ; il est recommandé aux inscrits de se connecter plus de 15 minutes à l’avance. Une transmission en direct et en archivage sera disponible sur le site investisseurs de l’entreprise à https://investors.outsetmedical.com/.

Outset Medical (Nasdaq: OM) wird seine Finanzergebnisse für das dritte Quartal 2025 nach Börsenschluss am Montag, 10. November 2025 bekannt geben. Eine Telefonkonferenz zur Besprechung der finanziellen und operativen Ergebnisse findet am selben Tag um 13:30 Uhr Pazifikzeit / 16:30 Uhr Ostküstenzeit mit dem Vorsitzenden und CEO Leslie Trigg und der CFO Renee Gaeta statt.

Interessierte Teilnehmer müssen sich online registrieren, um Einwahlnummern und eine einzigartige PIN zu erhalten; es wird empfohlen, sich mehr als 15 Minuten vor Beginn anzumelden. Eine Live- und Archiv-Webcast wird auf der Investoren-Website des Unternehmens unter https://investors.outsetmedical.com/ verfügbar sein.

Outset Medical (نازداك: OM) ستصدر نتائجها المالية للربع الثالث 2025 بعد إغلاق السوق يوم الإثنين 10 نوفمبر 2025. ستُعقد مكالمة المؤتمر لمناقشة النتائج المالية والتشغيلية في ذات اليوم عند 1:30 مساءً بتوقيت المحيط الهادئ / 4:30 مساءً بتوقيت شرق الولايات المتحدة مع رئيسة مجلس الإدارة والرئيسة التنفيذية Leslie Trigg والمديرة المالية Renee Gaeta.

يجب على المشاركين المهتمين التسجيل عبر الإنترنت لاستلام أرقام الاتصال ورمز PIN فريد؛ يُنصح المشاركون بالتسجيل والانضمام قبل أكثر من 15 دقيقة. سيكون هناك بث حي ومتابع على موقع المستثمرين للشركة على https://investors.outsetmedical.com/.

Outset Medical (纳斯达克: OM) 将在市场收盘后公布其2025 年第三季度财务业绩,时间为2025 年 11 月 10 日(星期一)。同日将举行一场电话会议,讨论财务与运营业绩,时间为太平洋时间 1:30 下午 / 东部时间 4:30 下午,由董事长兼首席执行官 Leslie Trigg 及首席财务官 Renee Gaeta 主持。

有意参加者须在线注册以获取拨入号码和唯一的 PIN;建议注册者提前超过 15 分钟加入。公司投资者网站 https://investors.outsetmedical.com/ 将提供直播与归档网络广播。

Positive
  • None.
Negative
  • None.

SAN JOSE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter 2025 after the close of trading on Monday, November 10, 2025.

On the same day, at 1:30 p.m. Pacific time (4:30 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Renee Gaeta, Chief Financial Officer, will host a conference call to discuss financial and operating results.

Conference Call Details
The conference call will begin at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) on Monday, November 10, 2025. Those interested in joining the conference call may do so by registering online. Once registered, participants will receive dial-in numbers and a unique pin to join the call. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.
Outset is a medical technology company transforming the dialysis experience across the continuum of care with a first-of-its-kind technology. The Tablo® Hemodialysis System, FDA-cleared for use from hospital to home, is trusted by more than 1,000 U.S. healthcare facilities and has enabled millions of treatments delivered by thousands of nurses. Designed to reduce the cost and complexity of dialysis, Tablo combines water purification and on-demand dialysate production into a single, integrated system that connects seamlessly with Electronic Medical Record systems and a proprietary data analytics platform. This enterprise solution empowers providers to develop an in-house dialysis program where they are in control – enabling better operational, clinical, and financial outcomes. Outset is redefining what’s possible in kidney care through innovation, scale, and a relentless commitment to improving the lives of patients and the professionals who care for them. For more information, visit www.outsetmedical.com.

Contact
Jim Mazzola
jmazzola@outsetmedical.com


FAQ

When will Outset Medical (OM) report Q3 2025 results?

Outset Medical (OM) will release Q3 2025 financial results after the close on Monday, November 10, 2025.

What time is the Outset Medical (OM) Q3 2025 conference call on November 10, 2025?

The conference call is scheduled for 1:30 p.m. Pacific / 4:30 p.m. Eastern on November 10, 2025.

Who will host Outset Medical’s (OM) Q3 2025 earnings call?

Leslie Trigg, Chair and CEO, and Renee Gaeta, CFO, will host the Q3 2025 earnings call.

How do investors join the Outset Medical (OM) November 10, 2025 webcast?

Investors should register online to receive dial-in numbers and a unique PIN; the live and archived webcast will be on https://investors.outsetmedical.com/.

Is the Outset Medical (OM) Q3 2025 call available after the live event?

Yes. A replay (archived webcast) will be available on the company’s Investors website after the live event.

When should I register for the Outset Medical (OM) November 10, 2025 call?

Participants are encouraged to register more than 15 minutes before the 1:30 p.m. Pacific start time to receive dial-in details and PIN.
Outset Medical, Inc.

NASDAQ:OM

OM Rankings

OM Latest News

OM Latest SEC Filings

OM Stock Data

224.39M
16.45M
2.7%
103.3%
10.98%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SAN JOSE